Value of whole-body contrast-enhanced magnetic resonance angiography with vessel wall imaging in quantitative assessment of disease activity and follow-up examination in Takayasu's arteritis

详细信息    查看全文

• 作者：Ying Sun ; Lili Ma ; Zongfei Ji ; Zhuojun Zhang ; Huiyong Chen…
• 关键词：Disease activity ; Follow ; up ; Magnetic resonance imaging (MRI) ; Quantitative MR scores ; Takayasu’s arteritis (TA)
• 刊名：Clinical Rheumatology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：35
• 期：3
• 页码：685-693
• 全文大小：1,335 KB
• 参考文献：1.Johnston SL, Lock RJ, Gompels MM (2002) Takayasu’s arteritis: a review. J Clin Pathol 55:481–486CrossRef PubMed PubMedCentral
  2.Matsuura K, Ogino H, Kobayashi J et al (2005) Surgical treatment of aortic regurgitation due to Takayasu arteritis: long-term morbidity and mortality. Circulation 112:3707–3712CrossRef PubMed
  3.Kerr GS, Hallahan CW, Giordano J et al (1994) Takayasu arteritis. Ann Intern Med 120:919–929CrossRef PubMed
  4.Andrews J, Mason JC (2007) Takayasu’s arteritis—recent advances in imaging offer promise. Rheumatology (Oxford) 46:6–15CrossRef PubMed
  5.Chung JW, Kim HC, Choi YH et al (2007) Patterns of aortic involvement in Takayasu’s arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 45:906–914CrossRef PubMed
  6.Giodrana P, Baqué-Juston MC, Jeandel PY et al (2011) Contrast-enhanced ultrasound of carotid artery wall in Takayasu’s disease: first evidence of application in diagnosis and monitoring response to treatment. Circulation 124:245–247CrossRef
  7.Lee KH, Cho A, Choi YJ et al (2012) The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with Takayasu’s arteritis. Arthritis Rheum 64:866–875CrossRef PubMed
  8.Wasserman BA, Astor BC, Sharrett AR et al (2010) MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics. J Magn Reson Imaging 31:406–415CrossRef PubMed PubMedCentral
  9.Laible M, Schoenberg SO, Weckbach S et al (2012) Whole-body MRI and MRA for evaluation of the prevalence of atherosclerosis in a cohort of subjectively healthy individuals. Insight Imaging 3:485–493CrossRef
  10.Filer A, Nicholls D, Corston R et al (2001) Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage. J Rheumatol 28:2752–2753PubMed
  11.Ragab Y, Emad Y, El-Marakbi A et al (2007) Clinical utility of magnetic resonance angiography (MRA) in the diagnosis and treatment of Takayasu’s arteritis. Clin Rheumatol 26:1393–1395CrossRef PubMed
  12.Hansen T, Wikstrom J, Eriksson MO et al (2006) Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol 16:147–153CrossRef PubMed
  13.Desai MY, Stone JH, Foo TK et al (2005) Delayed contrast-enhanced MRI of the aortic wall in Takayasu’s arteritis: initial experience. AJR 184:1427–1431CrossRef PubMed
  14.Lin J, Chen B, Wang JH et al (2006) Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases. Heart Vessels 21:395–398CrossRef PubMed
  15.Jiang L, Li D, Yan F et al (2012) Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol 155:262–267CrossRef PubMed
  16.Arend WP, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu’s arteritis. Arthritis Rheum 33:1129–1134CrossRef PubMed
  17.Lupi-Herrera E, Sanchez-Torres G, Marcushamer J et al (1977) Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 93:94–103CrossRef PubMed
  18.Misra R, Danada D, Rajapa SM et al (2013) Development and validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford) 52:1795–1801CrossRef PubMed
  19.Sider L, Mintzer RA, Vrla RF et al (1985) Use of DSA for diagnosis of Takayasu’s arteritis. IMJ III Med J 167:53–55
  20.Papa M, De Cobelli F, Baldissera E et al (2012) Takayasu’s arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol 198:279–284CrossRef
  21.Schneeweis C, Schnackenburg B, Stuber M et al (2012) Delayed contrast-enhanced MRI of the coronary artery wall in takayasu’s arteritis. PLoS One 7:e50655CrossRef PubMed PubMedCentral
  22.Sun Y, Ma L, Jiang L et al (2012) MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu’s arteritis. Int J Cardiol 156:236–238CrossRef PubMed
  23.Maekawa Y, Nagai T, Anzai A (2011) Pentraxins: CRP and PTX-3 and cardiovascular disease. Inflamm Allergy Drug Targets 10:229–235CrossRef PubMed
  24.Eshet Y, Pauzner R, Goitein O et al (2011) The limited role of MRI in long-term follow-up of patients with Takayasu’s arteritis. Autoimmun Rev 11:132–136CrossRef PubMed
  
• 作者单位：Ying Sun (1)
  Lili Ma (1)
  Zongfei Ji (1)
  Zhuojun Zhang (1)
  Huiyong Chen (1)
  Hao Liu (2)
  Yan Shan (2)
  Fuhua Yan (2)
  Lindi Jiang (1)
  
  1. Department of Rheumatology, Zhongshan Hospital, Fudan University, No. 180, Road Fenglin, Shanghai, 200032, People’s Republic of China
  2. Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Rheumatology
  
• 出版者：Springer London
• ISSN：1434-9949

文摘

The aim of this study is to determine the value of whole-body contrast-enhanced magnetic resonance angiography(CE-MRI) with vessel wall imaging in quantitative assessments of Takayasu’s arteritis (TA) disease activity and follow-up examinations. Whole-body CE-MRI with vessel wall imaging (dark blood sequences) was performed in 52 TA patients and repeated in 15 patients after 6 months. Images were analyzed using quantitative scores. The distribution of Lupi-Herrera types (type III, 48.1 %; I, 40.4 %; II, 9.6 %; IV, 1.9 %) did not differ between active and inactive TA. Active vessel inflammation was found in seven patients diagnosed with inactive disease as Kerr scores and mainly involved the aortic arch, abdominal aorta, and ascending aorta. Quantitative MR scores were significantly higher in active TA (luminal stenosis 16.7 ± 5.3 vs. 4.2 ± 3.7, p < 0.01; wall thickening 7.2 ± 3.4 vs. 2.9 ± 2.3, p = 0.02; wall enhancement 8.7 ± 4.1 vs. 3.6 ± 2.4, p = 0.04) and positively correlated with Kerr scores, ITAS 2010, erythrocyte-sedimentation rate (ESR), and C-reactive protein (CRP) and pentraxin-3 (PTX-3) levels. At 6 months, the clinical symptoms, CRP level, and ESR improved significantly (p < 0.05) and wall enhancement decreased (6.7 ± 3.1 vs. 4.1 ± 2.1; p = 0.04), but the luminal stenosis (10.2 ± 4.3 vs. 8.8 ± 5.2; p = 0.12) and wall thickening (6.3 ± 3.8 vs. 5.8 ± 4.2; p = 0.27) remained unchanged. Whole-body CE-MRI with vessel wall imaging detected luminal changes and vessel wall inflammation in TA. Our MR scoring system enabled quantitative assessment of TA activity.